News Daily News Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry Michael O'Riordan September 13, 2016
News Daily News Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients L.A. McKeown August 11, 2016
News Daily News El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI L.A. McKeown August 11, 2016
Presentation Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients Presenter: Raffaele Piccolo August 10, 2016
News Daily News Genetically Dictated Higher Lipid Levels Seem to Protect Against Type 2 Diabetes Todd Neale August 04, 2016
News Daily News Los Niveles Altos de Lípidos Dictados Genéticamente Parecen Proteger Frente a la Diabetes Tipo 2 Todd Neale August 04, 2016
News Daily News AstraZeneca Strives to Block Generic Crestor as Observers Call Foul Michael O'Riordan July 13, 2016
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News Los Fibroateromas de Casquete Fino Podrían Explicar los Malos Resultados PCI de los Pacientes Diabéticos Todd Neale July 06, 2016
News Daily News Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina Michael O'Riordan June 30, 2016
News Daily News Don’t Dismiss Diabetes: Long-Term Mortality After Acute MI Linked With the Disease in Large Population Study Yael L. Maxwell June 29, 2016
News Daily News Un Estudio Revela un Sorprendente Rango de Riesgo Post-IAM entre Pacientes con Diabetes L.A. McKeown May 26, 2016
News Daily News Study Shows Surprising Range of Risk After Acute MI Among Patients With Diabetes L.A. McKeown May 26, 2016
News Daily News Guidelines Notwithstanding, More Diabetics with Multivessel CAD Receive PCI Than CABG Yael L. Maxwell May 13, 2016
Presentation Revascularization Trends in Pts with Diabetes and Multivessel CAD Presenting with NSTEMI Presenter: Ambarish Pandey May 12, 2016
News Daily News Cada Vez Más Evidencias Confirman que No hay un Mayor Riesgo de Insuficiencia Cardíaca asociado a los Fármacos Antidiabéticos basados en la Incretina Michael O'Riordan March 25, 2016